SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-21-017698
Filing Date
2021-01-26
Accepted
2021-01-26 16:10:58
Documents
1
Effectiveness Date
2021-01-26

Document Format Files

Seq Description Document Type Size
1 S-8 POS d61261ds8pos.htm S-8 POS 22930
  Complete submission text file 0001193125-21-017698.txt   23941
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-225798 | Film No.: 21554167
SIC: 2834 Pharmaceutical Preparations